Fujian Cosunter Pharmaceutical Co Ltd Asset Resilience Ratio
Fujian Cosunter Pharmaceutical Co Ltd asset resilience ratio. Fujian Cosunter Pharmaceutical Co Ltd (300436) has an Asset Resilience Ratio of -2.56% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Fujian Cosunter Pharmaceutical Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Fujian Cosunter Pharmaceutical Co Ltd (2015–2016)
Asset resilience ratio of Fujian Cosunter Pharmaceutical Co Ltd from 2015 to 2016. This chart shows how Fujian Cosunter Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read Fujian Cosunter Pharmaceutical Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Fujian Cosunter Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Fujian Cosunter Pharmaceutical Co Ltd's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥-43.49 Million | -2.56% |
| Total Liquid Assets | CN¥-43.49 Million | -2.56% |
Asset Resilience Insights
- Limited Liquidity: Fujian Cosunter Pharmaceutical Co Ltd maintains only -2.56% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Fujian Cosunter Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Fujian Cosunter Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Galderma Group N
SW:GALD |
Drug Manufacturers - Specialty & Generic | 3.56% |
|
Enzymatica publ AB
ST:ENZY |
Drug Manufacturers - Specialty & Generic | 22.17% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
Fujian Cosunter Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2015–2016)
Fujian Cosunter Pharmaceutical Co Ltd asset resilience ratio by year from 2015 to 2016. The table below shows the annual Asset Resilience Ratio data for Fujian Cosunter Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2016-12-31 | 7.14% | CN¥50.00 Million ≈ $7.32 Million |
CN¥700.67 Million ≈ $102.53 Million |
-42.81pp |
| 2015-12-31 | 49.94% | CN¥300.00 Million ≈ $43.90 Million |
CN¥600.70 Million ≈ $87.90 Million |
-- |
About Fujian Cosunter Pharmaceutical Co Ltd
Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. The company offers drugs for anti-HBV, liver diseases, hepatobiliary disease drugs, metabolism and digestive system, respiratory, cardiovascular, men's health, and other fields. It also provides technical services such as drug development, including the deve… Read more